Abbott Laboratories Stock News

ARGA Investment Management LP lowered its stake in shares of Abbott Laboratories (NYSE:ABT) by 21.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 6,214 shares of the healthcare product makers stock after selling 1,709 shares during the period. ARGA Investment Management LPs holdings in Abbott Laboratories were []

DUBLIN--(BUSINESS WIRE)--The "Global Home-care Monitoring and Diagnostics Market 2021-2025" report has been added to ResearchAndMarkets.com''s offering. The publisher has been monitoring the home-care monitoring and diagnostics market and it is poised to grow by $8.51 billion during 2021-2025, progressing at a CAGR of 9.06% during the forecast period. The report on the home-care monitoring and diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and

Diversey Holdings, Ltd. (NASDAQ:DSEY) with the stream of -2.33% also noticed, India Abbott Laboratories (NYSE:ABT) encountered a rapid change of 0.39% in the last hour of Thursdays trading session. Diversey The post Stocks Stunning Activities: Diversey Holdings, Ltd. (NASDAQ:DSEY), Abbott Laboratories (NYSE:ABT) appeared first on Stocks Equity .

Here's why you might want to own Pfizer, Merck, or Abbott Labs next year.

Terra Nova Asset Management LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT) by 18.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,246 shares of the healthcare product makers stock after buying an additional 2,027 shares during the period. Terra Nova Asset Management []

The Global Non- Invasive Biosensors Market Report 2022 to 2027 could be a fundamental examination of the global analysis. Trending innovation, advertise drivers, sectional declination, analysis measurements, advertise forecasts, manufacturers, and hardware merchants are all included within the substance. The

Pet Health Products Market Survival Strategies explore Economic Impact in International Industries Manufactures, Growth, Size, Share, Trends, Development Challenges and Opportunities till 2028. The new research on Pet Health Products gives a fundamental data and factually assessed information about the

Tower Bridge Advisors raised its stake in Abbott Laboratories (NYSE:ABT) by 1.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,550 shares of the healthcare product makers stock after acquiring an additional 1,034 shares during the quarter. Tower Bridge Advisors holdings []

Silver Lake Advisory LLC lifted its stake in Abbott Laboratories (NYSE:ABT) by 0.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 43,239 shares of the healthcare product makers stock after acquiring an additional 215 shares during the period. Abbott []

Sterling Financial Planning Inc. lowered its holdings in Abbott Laboratories (NYSE:ABT) by 10.3% during the third quarter, Holdings Channel.com reports. The firm owned 1,077 shares of the healthcare product makers stock after selling 123 shares during the period. Sterling Financial Planning Inc.s holdings in Abbott Laboratories were worth $127,000 at the end of the most []

Independent Investors Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT) by 1.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 44,050 shares of the healthcare product makers stock after selling 850 shares during the period. Abbott Laboratories accounts []

Abbott (ABT) closed the most recent trading day at $135.56, moving +1.97% from the previous trading session.

Livforsakringsbolaget Skandia Omsesidigt trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT) by 6.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 72,017 shares of the healthcare product makers stock after selling 5,300 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigts []

The Cytomegalovirus (CMV) Diagnostic research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Cytomegalovirus (CMV) Diagnostic research report offers information